| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | Director | Common Stock | 8.77K | $28.9K | $3.30 | Jan 2, 2025 | Direct |
| Cartesian Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 7.8K | $6.16K | $0.79 | Jan 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Director |
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director |
| SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 3 | -$69.8K | 4 | Nov 15, 2023 | Director |
| SELB | SELECTA BIOSCIENCES INC | Jan 2, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| SELB | SELECTA BIOSCIENCES INC | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
| SELB | SELECTA BIOSCIENCES INC | Dec 2, 2021 | 1 | $20.7K | 4 | Dec 6, 2021 | Director |
| SELB | SELECTA BIOSCIENCES INC | Jun 23, 2021 | 1 | $0 | 4 | Jul 9, 2021 | Director |
| SELB | SELECTA BIOSCIENCES INC | Jun 23, 2021 | 0 | $0 | 3 | Jul 9, 2021 | Director |